Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Down 10.0% in July

Enzo Biochem, Inc. (NYSE:ENZ) saw a significant decrease in short interest in the month of July. As of July 31st, there was short interest totalling 531,800 shares, a decrease of 10.0% from the July 15th total of 591,200 shares. Based on an average daily trading volume, of 119,600 shares, the days-to-cover ratio is presently 4.4 days. Currently, 1.5% of the company’s shares are short sold.

Enzo Biochem Stock Down 1.8 %

NYSE:ENZ traded down $0.02 during trading hours on Monday, hitting $1.11. 39,321 shares of the company were exchanged, compared to its average volume of 107,406. Enzo Biochem has a one year low of $0.99 and a one year high of $1.68. The company has a fifty day simple moving average of $1.11 and a 200 day simple moving average of $1.17.

Enzo Biochem (NYSE:ENZ) last announced its earnings results on Thursday, June 13th. The medical research company reported ($0.03) EPS for the quarter. Enzo Biochem had a net margin of 134.17% and a negative return on equity of 21.50%. The company had revenue of $8.02 million during the quarter.

Institutional Investors Weigh In On Enzo Biochem

Several large investors have recently added to or reduced their stakes in ENZ. Renaissance Technologies LLC grew its holdings in Enzo Biochem by 2.6% in the second quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after purchasing an additional 64,417 shares during the period. Wittenberg Investment Management Inc. acquired a new stake in shares of Enzo Biochem in the 4th quarter valued at about $95,000. Finally, XTX Topco Ltd increased its position in Enzo Biochem by 94.5% in the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after buying an additional 13,735 shares in the last quarter. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.